Niki Karavitaki Selected Research

Prolactinoma (Prolactinomas)

11/2019	MANAGEMENT OF ENDOCRINE DISEASE: Visual morbidity in patients with pituitary adenoma.
1/2019	Association of prolactin receptor (PRLR) variants with prolactinomas.
1/2018	Males with prolactinoma are at increased risk of incident cardiovascular disease.
1/2018	Macroprolactinoma causing VI, X, XII cranial nerve palsies nearly 30 years after initial treatment.
1/2018	Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal.
11/2017	Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes.
9/2016	THERAPY OF ENDOCRINE DISEASE: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature.
2/2016	Treating prolactinomas with dopamine agonists: always worth the gamble?
1/2016	A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology.
1/2015	Pituitary disorders in pregnancy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niki Karavitaki Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2008
16	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 02/2007
14	Prolactinoma (Prolactinomas) 11/2019 - 10/2006
12	Adenoma (Adenomas) 01/2021 - 03/2004
11	Pituitary ACTH Hypersecretion 12/2021 - 03/2004
8	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2022 - 08/2010
7	Hyperprolactinemia 02/2022 - 10/2006
6	Acromegaly 01/2018 - 01/2004
5	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2022 - 01/2013
5	Cushing Syndrome 01/2021 - 06/2005
5	Hypopituitarism (Sheehan's Syndrome) 01/2018 - 09/2009
4	Carcinogenesis 01/2022 - 01/2008
3	Hypothyroidism 11/2022 - 02/2016
3	ACTH-Secreting Pituitary Adenoma 01/2022 - 04/2015
3	Craniopharyngioma (Craniopharyngiomas) 01/2022 - 01/2017
3	Diabetes Insipidus 01/2018 - 10/2014
3	Pheochromocytoma 01/2016 - 08/2012
3	Growth Hormone-Secreting Pituitary Adenoma 12/2014 - 08/2012
3	Thyroid Neoplasms (Thyroid Cancer) 04/2014 - 07/2002
2	Pituitary Diseases (Disease, Anterior Pituitary) 02/2022 - 11/2019
2	Hyperplasia 01/2022 - 11/2015
2	Sepsis (Septicemia) 01/2020 - 08/2012
2	Pituitary Apoplexy 11/2019 - 04/2011
2	Pain (Aches) 10/2018 - 01/2014
2	Chronic Pain 10/2018 - 01/2014
2	Heart Valve Diseases (Valvular Heart Disease) 11/2016 - 01/2009
2	Ectopic ACTH Syndrome 11/2015 - 08/2012
2	Adrenocortical Carcinoma 11/2015 - 01/2013
2	Central Nervous System Cysts (Suprasellar Cyst) 01/2014 - 02/2012
2	Cysts 01/2014 - 02/2012
1	Hyperthyroidism 11/2022
1	Opioid-Related Disorders (Opiate Addiction) 02/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	COVID-19 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Addison Disease (Addison's Disease) 01/2020
1	Hypotension (Low Blood Pressure) 12/2019
1	Hypertension (High Blood Pressure) 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Congenital Heart Defects (Congenital Heart Defect) 11/2016
1	Endocrine System Diseases (Endocrine Diseases) 09/2016
1	Stroke (Strokes) 02/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Cardiotoxicity 01/2016
1	Inappropriate ADH Syndrome (SIADH) 07/2015
1	Craniocerebral Trauma (Head Injury) 07/2015

Drug/Important Bio-Agent (IBA)

13	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 03/2004
8	Hormones (Hormone)IBA 01/2020 - 08/2013
8	Dopamine Agonists (Dopamine Agonist)IBA 11/2019 - 10/2006
7	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2021 - 08/2012
7	ProlactinIBA 12/2019 - 10/2006
5	Opioid Analgesics (Opioids)IBA 02/2022 - 08/2010
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2004
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 03/2005
4	Cabergoline FDA LinkGeneric 11/2016 - 01/2009
3	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2004
3	Insulin-Like PeptidesIBA 01/2022 - 01/2008
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022 - 07/2002
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 11/2011
2	GadoliniumIBA 02/2019 - 01/2016
2	CateninsIBA 01/2017 - 02/2007
2	Pharmaceutical PreparationsIBA 11/2016 - 01/2016
2	aryl hydrocarbon receptor-interacting proteinIBA 11/2014 - 08/2012
2	Capsules (Microcapsules)IBA 01/2014 - 02/2012
2	GlucocorticoidsIBA 01/2013 - 06/2005
2	lanreotide (Somatuline)FDA Link 08/2012 - 03/2005
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2022
1	Protons (Proton)IBA 01/2022
1	Cytidine Triphosphate (CTP)IBA 03/2021
1	N 30IBA 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 12/2019
1	NormetanephrineIBA 12/2019
1	ElementsIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 11/2019
1	Contrast MediaIBA 02/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2016
1	amsonic acid (DAS)IBA 01/2016
1	CatecholaminesIBA 01/2016
1	Metyrapone FDA Link 11/2015
1	ElectrolytesIBA 07/2015
1	Vasopressins (Vasopressin)IBA 07/2015
1	SteroidsIBA 05/2015

Therapy/Procedure

16	Therapeutics 01/2020 - 07/2002
15	Radiotherapy 01/2022 - 09/2009
3	Adrenalectomy 03/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 12/2019 - 08/2012
2	Colonic Pouches (S Pouch) 01/2014 - 02/2012
1	Intravenous Infusions 01/2020
1	Surgical Decompression 11/2019
1	Complementary Therapies (Alternative Medicine) 10/2018
1	Adjuvant Radiotherapy 01/2018
1	Duration of Therapy 01/2018
1	Injections 03/2016